Pedro Faria Zeni
Research specialist - PhD student, Marek Mráz Research Group
Office: bldg. E35/275
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8144 |
---|---|
E‑mail: |
Total number of publications: 24
2023
-
FOX01-rictor AXIS induces AKT phosporylation during CLL cell adaptation to BCR inhibitors: Implications for combinatorial therapy.
Year: 2023, type: Conference abstract
-
FOXO1-RICTOR AXIS induces adaptive increase in AKT activity during BCR inhibitor therapy in CLL: Implications for combination therapy.
Year: 2023, type: Conference abstract
-
Foxo1-Rictor axis mediates adaptive increase in Akt activity and cell survival during BCR inhibitor therapy in chronic lymphocytic leukemia.
Year: 2023, type: Conference abstract
-
Nekódující RNA v biologii maligních B lymfocytů.
Year: 2023, type: Conference abstract
-
Transcription factor FoxO1 Mediates Adaptive Increase in Akt Activity and Cell Survival During BCR Inhibitor Therapy in CLL.
Year: 2023, type: Conference abstract
-
Transkripční faktor FoxO1 v adaptaci chronické lymfocytární leukémie na cílenou léčbu.
Year: 2023, type: Conference abstract
2022
-
Adaptace buněk chronické lymfocytární leukémie na cílenou léčbu BCR inhibitory.
Year: 2022, type: Conference abstract
-
Modelling chronic lymphocytic leukaemia microenvironment.
Year: 2022, type: Conference abstract
-
The role of long non-coding RNAs in BCR-mediated CLL activation.
Year: 2022, type: Conference abstract
-
The role of long non-coding RNAs in the microenvironmental interactions of malignant B cells.
Year: 2022, type: Conference abstract